Insulin glargine and lixisenatide Subcutaneous and Zemplar (Paricalcitol Capsules)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Zemplar (Paricalcitol Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Zemplar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Zemplar (Paricalcitol Injection)
- Insulin glargine and lixisenatide Subcutaneous-Zemplar Injection
- Insulin glargine and lixisenatide Subcutaneous-Zemplar Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Zemuron
- Insulin glargine and lixisenatide Subcutaneous-Zenapax
- Insulin glargine and lixisenatide Subcutaneous-Zenatane
- Zemplar (Paricalcitol Capsules)-Insulin glargine, recombinant Subcutaneous
- Zemplar (Paricalcitol Capsules)-Insulin glulisine
- Zemplar (Paricalcitol Capsules)-Insulin Glulisine (Cartridges and Pens)
- Zemplar (Paricalcitol Capsules)-Insulin Glulisine (Vials)
- Zemplar (Paricalcitol Capsules)-Insulin glulisine Subcutaneous
- Zemplar (Paricalcitol Capsules)-Insulin human inhaled Inhalation